Position in NBIX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$5,730
-$950 QoQ
Shares Held
34
-48.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#706
of 768 holders
Holding Since
Sep 2022
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $7,382 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (77.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
34 | $5,730 | |
| 2 | ZTS |
Zoetis Inc.
|
23 | $1,652 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,730 | 34 | Shares | Sole | 2026-07-21 | |
| 2023-03-31 | $6,680 | 66 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $4,419 | 37 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,867 | 27 | Shares | Sole | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||